Citigroup Inc. Decreases Position in Ralliant Corporation $RAL

Citigroup Inc. reduced its stake in shares of Ralliant Corporation (NYSE:RAL) by 60.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 73,076 shares of the company’s stock after selling 113,758 shares during the quarter. Citigroup Inc. owned 0.06% of Ralliant worth $3,196,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Arizona State Retirement System grew its position in Ralliant by 1.2% in the third quarter. Arizona State Retirement System now owns 33,566 shares of the company’s stock valued at $1,468,000 after acquiring an additional 413 shares in the last quarter. Manchester Capital Management LLC acquired a new stake in Ralliant during the 2nd quarter valued at $29,000. Westfuller Advisors LLC acquired a new stake in Ralliant during the 3rd quarter valued at $26,000. GAMMA Investing LLC increased its stake in Ralliant by 57.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,801 shares of the company’s stock worth $79,000 after buying an additional 654 shares during the period. Finally, UMB Bank n.a. acquired a new position in Ralliant in the 3rd quarter worth $29,000.

Wall Street Analyst Weigh In

RAL has been the subject of several recent analyst reports. Barclays lowered their target price on Ralliant from $60.00 to $52.00 and set an “overweight” rating for the company in a research note on Monday, February 9th. Vertical Research upgraded Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a research note on Friday, February 6th. Truist Financial cut their target price on Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Weiss Ratings cut Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research note on Thursday, February 5th. Finally, Zacks Research lowered shares of Ralliant from a “hold” rating to a “strong sell” rating in a research note on Monday, February 9th. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $50.50.

Ralliant Stock Performance

Shares of RAL opened at $46.36 on Friday. The stock has a market capitalization of $5.18 billion and a PE ratio of 23.65. The business’s fifty day moving average price is $49.08 and its 200 day moving average price is $46.63. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. Ralliant Corporation has a 12-month low of $37.27 and a 12-month high of $57.02.

Ralliant (NYSE:RAL) last released its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The company’s revenue for the quarter was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be issued a $0.05 dividend. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. Ralliant’s dividend payout ratio (DPR) is currently 10.20%.

Insider Buying and Selling

In related news, SVP Amir A. Kazmi bought 2,545 shares of the stock in a transaction dated Friday, February 6th. The stock was bought at an average cost of $39.27 per share, with a total value of $99,942.15. Following the completion of the acquisition, the senior vice president owned 39,699 shares of the company’s stock, valued at $1,558,979.73. This trade represents a 6.85% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kate Mitchell purchased 2,350 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were bought at an average price of $42.48 per share, for a total transaction of $99,828.00. Following the completion of the transaction, the director directly owned 8,411 shares in the company, valued at approximately $357,299.28. This trade represents a 38.77% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 8,145 shares of company stock valued at $332,233 over the last 90 days.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.